Patents by Inventor Andrew Garst

Andrew Garst has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CRISPR ENABLED MULTIPLEXED GENOME ENGINEERING
    Publication number: 20170321226
    Abstract: Described herein are methods and vectors for rational, multiplexed manipulation of chromosomes within open reading frames (e.g., in protein libraries) or any segment of a chromosome in a cell or population of cells, in which various CRISPR systems are used.
    Type: Application
    Filed: June 22, 2017
    Publication date: November 9, 2017
    Inventors: Ryan T. GILL, Andrew GARST
  • CRISPR ENABLED MULTIPLEXED GENOME ENGINEERING
    Publication number: 20170240922
    Abstract: Described herein are methods and vectors for rational, multiplexed manipulation of chromosomes within open reading frames (e.g., in protein libraries) or any segment of a chromosome in a cell or population of cells, in which various CRISPR systems are used.
    Type: Application
    Filed: February 11, 2015
    Publication date: August 24, 2017
    Inventors: Ryan T. GILL, Andrew GARST
  • MULTIPLEXED LINKING PCR
    Publication number: 20170009283
    Abstract: The invention provides compositions and methods for rapid assembly of one or more assembled polynucleotides from a plurality of component polynucleotides, as well as methods of designing polynucleotide primer and linker sets useful in the assembly methods of the invention.
    Type: Application
    Filed: February 9, 2015
    Publication date: January 12, 2017
    Applicant: THE REGENTS OF THE UNIVERSITY OF COLORADO, a body corporate
    Inventors: Ryan T. GILL, Ramsey ZEITOUN, Andrew GARST
  • LYSINE RIBOSWITCH AND COMPOSITIONS AND USES THEREOF
    Publication number: 20110206693
    Abstract: Embodiments herein provide for lysine riboswitches and analogs thereof, and methods for using the same. In certain embodiments, test compounds are identified that associate with lysine riboswitches. In other embodiments, test compounds found to associate with lysine can be used to increase or decrease gene expression of Gram-negative bacterial organisms.
    Type: Application
    Filed: April 14, 2009
    Publication date: August 25, 2011
    Inventors: Robert Batey, Andrew Garst